Development of antibody functionalized magnetic nanoparticles for immunoassay of carcinoembryonic antigen: Feasibility study for clinic use

Written By Yiran Gan
Development of antibody functionalized magnetic nanoparticles for immunoassay of carcinoembryonic antigen: Feasibility study for clinic use - Yang et al. 2014

Development of antibody functionalized magnetic nanoparticles for immunoassay of carcinoembryonic antigen: Feasibility study for clinic use

Publication Date: 2015.07.23

Authors: C.C. Yang, S.Y. Yang, C.S. Ho, J.F. Chang, B.H. Liu, and K.W. Huang

Journal: J. Nanobiotechnol.12: 10.1186/s12951-014-0044-6 (2014)

Authors

Citation

C.C. Yang, S.Y. Yang, C.S. Ho, J.F. Chang, B.H. Liu, and K.W. Huang, "Development of antibody functionalized magnetic nanoparticles for immunoassay of carcinoembryonic antigen: Feasibility study for clinic use", J. Nanobiotechnol.12: 10.1186/s12951-014-0044-6 (2014).

© 2014

Journal of Nanobiotechnology

Yiran Gan
Previous

A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay
Next

Plasma Aβ but not tau related to brain PiB retention in early Alzheimer’s disease